Technologieangebote

Scientists of the Saarland University and the Charité Berlin established an assay which allows the selective detection of all 14 clinically relevant variants…

This technology offer contains three patent applications of Saarland University that provide methods for the diagnosis of tumours in an early stage, especially…

An innovative cell based MMP bioassay was invented enabling high through-put screening of novel MMP inhibitors. The method is based on the heterologous…

Scientists of Saarland University have recently succeeded in developing an improved series of new non-steroidal inhibitors of 17b-HSD2. Since 17b-HSD2 is…

Scientists of Saarland University have recently succeeded in developing the first CYP11B1 inhibitors showing good selectivity. As starting point the highly…

Scientists of Saarland University have developed a setup, which allows a controlled manipulation of cells via cell‐surface‐interaction. Therefore biocompatible…